HIF-2α antagonist

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

VHL mutation	Clear Cell Renal Cell Carcinoma	VHL mutation	Clear Cell Renal Cell Carcinoma	MK-3795 Sensitive: C2 – Inclusion Criteria MK-3795 Sensitive : C2	MK-3795 Sensitive: C2 – Inclusion Criteria MK-3795 Sensitive : C2
VHL mutation	Neuroendocrine Tumor	VHL mutation	Neuroendocrine Tumor	MK-3795 Sensitive: C3 – Early Trials MK-3795 Sensitive : C3	MK-3795 Sensitive: C3 – Early Trials MK-3795 Sensitive : C3

Associations(2)